Furthermore, adiponectin is reported to be implicated not only in diabetes, dyslipidemia and hypertension as part of the metabolic syndrome, but in the onset of cancer associated with obesity. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.